Funding for this research was provided by:
Cancerfonden (Junior Clinical Investigator Award)
Svenska Sällskapet för Medicinsk Forskning (Stora Etableringsanslaget)
Received: 30 March 2021
Accepted: 21 July 2021
First Online: 14 August 2021
: The ethical application was approved by the Swedish Ethical Review Authority (approval no. 2015/959–31). Tumors and normal tissues from all patients were collected with written informed consent, as was the clinical information regarding all patients.
: The index patient and all patients included in the validation cohort have given their consent for publication when acknowledging the written informed consent.
: None declared.